For example, in prostate cancer cells DNMT1 was shown to play a tumor-suppressive role [57] while DNMT3B displayed oncogenic function by inducing EMT-associated phenotypes in head and neck squamous cell carcinoma, breast cancer, and ovarian cancer cells [58–60]. This evidence concerns the gene DNMT1 and ovarian carcinoma.